Randomized Trial Comparing Esomeprazole and Rabeprazole in First-line Eradication Therapy for <i>Helicobacter pylori</i> Infection based on the Serum Levels of Pepsinogens-Reference-Cited by-同舟云学术

Randomized Trial Comparing Esomeprazole and Rabeprazole in First-line Eradication Therapy for Helicobacter pylori Infection based on the Serum Levels of Pepsinogens

Published:2017 Issue:13 Volume:56 Page:1621-1627
ISSN:0918-2918
Container-title:Internal Medicine
language:en
Short-container-title:Intern. Med.

Author:

Shimoyama Tadashi¹,Chinda Daisuke¹,Sawada Yoshihiko²,Komai Kazuo³,Chiba Hironobu⁴,Saito Yoshiharu⁵,Sasaki Yoshio⁶,Matsuzaka Masashi⁷,Fukuda Shinsaku¹

Affiliation:

1. Department of Gastroenterology, Hirosaki University Graduate School of Medicine, Japan

2. Sawada Clinic of Internal Medicine, Japan

3. Komai Clinic of Gastroenterology and Internal Medicine, Japan

4. Sasaki Clinic of Gastroenterology and Internal Medicine, Japan

5. Chiba Clinic of Gastroenterology and Internal Medicine, Japan

6. Shinjo Clinic of Gastroenterology and Internal Medicine, Japan

7. Department of Cancer Epidemiology and Community Health, Hirosaki University Hospital, Japan

Publisher

Japanese Society of Internal Medicine

Subject

General Medicine,Internal Medicine

Link

https://www.jstage.jst.go.jp/article/internalmedicine/56/13/56_56.7823/_pdf

Reference24 articles.

1. 1. Li WQ, Ma JL, Zhang L, et al. Effects of Helicobacter pylori treatment on gastric cancer incidence and mortality in subgroups. J Natl Cancer Inst 106: dju116, 2014.

2. 2. Take S, Mizuno M, Ishiki K, et al. Seventeen-year effects of eradication of Helicobacter pylori on the prevention of gastric cancer in patients with peptic ulcer; a prospective cohort study. J Gastroenterol 50: 638-644, 2015.

3. 3. Herrero R, Park JY, Forman D. The fight against gastric cancer: the IARC Working Group report. Best Pract Res Clin Gastroenterol 28: 1107-1114, 2014.

4. 4. Asaka M, Kato M, Sakamoto N. Roadmap to eliminate gastric cancer with Helicobacter pylori eradication and consecutive surveillance in Japan. J Gastroenterol 49: 1-8, 2014.

5. 5. Asaka M, Kato M, Takahashi S, et al. Guidelines for the management of Helicobacter pylori infection in Japan: 2009 revised edition. Helicobacter 15: 1-20, 2010.

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A Vonoprazan, Clarithromycin, and Metronidazole Regimen as <i>Helicobacter pylori</i> Eradication Therapy for Patients with Penicillin Allergy in Light of Clarithromycin Resistance;Internal Medicine;2023-08-15

2. Antibiotic resistance in Helicobacter pylori: From potential biomolecular mechanisms to clinical practice;Journal of Clinical Laboratory Analysis;2023-04

3. Current status of gastric and oral infection/diseases caused by Helicobacter pylori;Oral Science International;2023-01-26

4. Network meta‐analysis of different dosages of esomeprazole and rabeprazole for the treatment of Helicobacter pylori;Helicobacter;2023-01-16

5. The CYP2C19 polymorphisms effects on H. pylori cure rate in proton pump inhibitor-based therapeutic regimens: An updated meta-analysis;Gene Reports;2021-12